HIV/AIDS Therapy
New findings in the area of HIV/AIDS therapy described
Published in AIDS Weekly, July 25th, 2005
Study 1: Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.
"The K103N mutation in HIV-1 reverse transcriptase (RT) confers high-level resistance to current non-nucleoside reverse transcriptase inhibitors (NNRTI). The prevalence and resistance profile of HIV-1 with other substitutions at RT codon 103 is less well documented. K103 substitutions among over 70,000 clinical samples submitted for routine antiretroviral resistance testing at two independent centers were examined,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-07-25)
More Articles from AIDS Weekly
- HIV/AIDS Drug Use
Cocaine upregulates DC-SIGN expression on dendritic cells in HIV infection - HIV/AIDS Healthcare
Satellite pharmacy at HIV clinic improves physician-pharmacist interaction - HIV/AIDS Prevention
Branded advertising campaign increases condom use in Tanzania - HIV/AIDS Viremia
Low-level viremia not uncommon during very early period of primary HIV infection - HIV/Tuberculosis Coinfection
T cell decrease in HIV/TB coinfection leads to marked cytokine reduction - Allergy and Immunology
Patients coinfected with hepatitis C and HIV mount a full response to F protein - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
